Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tempus AI Cl A (TEM)

Tempus AI Cl A (TEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Tempus Announces Collaboration with Median Technologies to Integrate AI-Powered Lung Cancer Screening into the Pixel Platform

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a collaboration with Median Technologies (EPA: ALMDT) to bring Median’s proprietary...

TEM : 51.92 (+2.24%)
As Crypto Prices Plunge, Cathie Wood Is Selling This 1 Bitcoin Stock

The crypto price crash has led to continued trouble for crypto stocks.

BLSH : 32.74 (+3.25%)
TER : 314.94 (+1.30%)
GOOG : 306.51 (-0.92%)
GOOGL : 305.98 (-0.98%)
^ETHUSD : 2,030.374 (+5.58%)
AVGO : 327.58 (-1.08%)
TTD : 25.95 (-0.73%)
CRCL : 59.49 (+5.05%)
^BTCUSDC : 68,660.41 (+4.38%)
COIN : 162.34 (+15.06%)
ARKK : 70.43 (+2.89%)
CRWV : 98.64 (+3.07%)
Tempus to Report Fourth Quarter and Full Year 2025 Financial Results on February 24

Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced they will report financial results for the fourth quarter and full year 2025 on Tuesday, February...

TEM : 51.92 (+2.24%)
Ambry’s Contributions to MAVEs Support Thousands of Patient Reclassifications and Expand to New Genes

New study published in Nature Communications builds on Ambry’s contributions to MAVE research to deepen understanding of PALB2 and its role in hereditary...

TEM : 51.92 (+2.24%)
Ambry Genetics Announces One Millionth Test Leveraging RNA to Improve Diagnostic Accuracy and Yield

Milestone highlights growing adoption of DNA and RNA-informed diagnostics for hereditary cancer and rare disease

TEM : 51.92 (+2.24%)
Cathie Wood Just Bet $26 Million on Broadcom Stock. Should You Buy AVGO Too?

Cathie Wood bets on Broadcom while shorting major market names in a week of activity.

BLSH : 32.74 (+3.25%)
ARKX : 31.52 (+1.84%)
NFLX : 76.08 (+0.29%)
META : 646.00 (-0.59%)
ROKU : 87.77 (+5.84%)
TXG : 19.44 (+11.02%)
GTLB : 29.74 (+0.54%)
AVGO : 327.58 (-1.08%)
TWST : 49.36 (+3.57%)
ILMN : 116.33 (+1.65%)
CRCL : 59.49 (+5.05%)
WRD : 7.62 (+2.14%)
Tempus Reveals Its AI-Driven IPS Test More Accurately Predicts Immunotherapy Benefit Compared to Conventional Biomarkers

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced results from a new study demonstrating that its algorithmic test, Immune...

TEM : 51.92 (+2.24%)
Pelosi’s Bullish 2026 Buy List: AI, Power & Dividends

The famous congressional portfolio is rotating capital into dividend-paying financial stocks while doubling down on artificial intelligence and energy.

AB : 40.68 (+0.39%)
NVDA : 183.24 (-1.98%)
GOOGL : 305.98 (-0.98%)
AAPL : 259.41 (-0.89%)
VST : 168.66 (+3.41%)
TEM : 51.92 (+2.24%)
AMZN : 198.64 (-0.48%)
Tempus Announces the Launch of Paige Predict

Following the acquisition of Paige in 2025, Tempus launches its new AI-powered, biomarker prediction solution for digital pathology

TEM : 51.92 (+2.24%)
Tempus and NYU Langone Health Announce Strategic Collaboration to Advance Precision Oncology

Tempus, a leader in artificial intelligence and precision medicine, and NYU Langone Health, one of the nation’s premier academic medical centers, today announced a multi-year strategic collaboration...

TEM : 51.92 (+2.24%)

Barchart Exclusives

As Oracle Lands a New Air Force Win, Should You Buy, Sell, or Hold ORCL Stock?
Oracle has won a fresh Air Force contract worth $88 million. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar